Clarametyx Biosciences

Clarametyx Biosciences develops targeted, immune-enabling biologic therapies to counter persistent infections associated with biofilms. The company focuses on chronic respiratory diseases and is building a pipeline of immune-enabling therapies and vaccines for serious bacterial infections. Their innovative technology platform targets the biofilm to enable a more effective immune response and antibiotic intervention.

Buy Funded Startups lists

Funding Round: Series A+

Funding Amount:

Date: 28-Jan-2025

Investors: Kineticos AMR Accelerator Fund I, L.P.

Markets: Biotechnology, Pharmaceuticals, Healthtech, Drug Discovery

HQ: Columbus, Ohio, United States

Founded: 2020

Website: https://www.clarametyx.com/

LinkedIn: https://www.linkedin.com/company/clarametyx-biosciences/

Twitter:

Instagram: